Responding to the All-Party Parliamentary Group on Blood Cancer’s report ‘The ‘Hidden’ Cancer: The need to improve blood cancer care’, published today, Anthony Nolan’s Policy and Public Affairs Manager Amelia Chong comments:
'Anthony Nolan welcomes this report from the APPG on Blood Cancer (APPGBC) and we look forward to continuing to work with them to improve blood cancer care in the NHS. In particular, we are pleased that the APPG recommends a review of the care currently provided to patients after a stem cell transplant. As highlighted by Anthony Nolan’s September 2017 report, ‘Recovery After Transplant: Who Cares’, the care and support that patients are able to access during their long-term recovery varies considerably across the country, and more work is needed to ensure that patients receive the support they need.
'We also support the APPGBC’s call for continued, stable investment in blood cancer research. In November 2017 Anthony Nolan partnered with Leuka, NHS Blood and Transplant and the University of Birmingham to launch IMPACT, an ambitious £4 million clinical trials programme aimed at saving and improving the lives of more stem cell transplant patients. With the first wave of trials beginning this year, this is the first step to improving the care received by transplant patients across the UK.'